Company: WLACW
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001493152-25-011863
Chunk: 41

Company: Willow Lane Acquisition Corp.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---

(the “Hearing Panel”), the scope of the Hearing Panel’s review is limited. If a SPAC completes a Business Combination
after receiving a delisting determination by the staff of the Listing Qualifications Department of Nasdaq (a “Staff Delisting Determination”)
and/or demonstrates compliance with all applicable initial listing requirements, the combined company can apply to list its securities
on Nasdaq pursuant to the normal application review process. The Nasdaq Rules contain a list of deficiencies that would immediately result
in a Staff Delisting Determination, which includes noncompliance with the Nasdaq 36-Month Requirement.

Accordingly, were we to
amend our Amended and Restated Articles to extend the date by which we are permitted to consummate our initial Business Combination, we
would still need to consummate our initial Business Combination on or prior to November 7, 2027, in order to avoid a suspension of our
securities from trading on and delisting from Nasdaq. If Nasdaq were to suspend our securities from trading and delist our securities,
our securities could potentially be quoted on an over-the-counter market. Even if our securities are then quoted on an over-the-counter
market, our Nasdaq suspension and delisting could have significant material adverse consequences, including:

·making our securities appear to be less attractive to potential
target companies than the securities of an exchange-listed SPAC;

·limited availability of market quotations for our securities;

·reduced liquidity for our securities;

·the possibility that our Class A Ordinary Shares would be
deemed “penny stock,” which will require brokers trading in our Class A Ordinary Shares to adhere to more stringent rules
and possibly result in a reduced level of trading activity in the secondary trading market for our securities;

·limited news and analyst coverage; and

·decreased ability to issue additional securities or obtain
additional financing in the future.

In addition, if our securities
are delisted from Nasdaq, trading in our securities, and offers and sales of our securities by us, may be subject to state securities
regulation and additional compliance costs. 

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered
Sales of Equity Securities

None.

Use
of Proceeds

For
a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 5 of our Annual
Report on Form 10-K for the fiscal year ended December 31, 202